Literature DB >> 15689935

Scientists for a better world.

Emmanuel G Reynaud1.   

Abstract

Mesh：

Year:  2005        PMID： 15689935      PMCID： PMC1299248          DOI： 10.1038/sj.embor.7400338

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  18 in total

1.  The rice genome. World poverty and hunger--the challenge for science.

Authors:  Ismail Serageldin
Journal:  Science       Date:  2002-04-05       Impact factor: 47.728

2.  Genomics and global health: time for a reappraisal.

Authors:  David J Weatherall
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

3.  Humanity as the model system.

Authors:  Sydney Brenner
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

4.  Building scientific capacity in developing countries.

Authors:  Eva Harris
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

5.  Cures for the Third World's problems: the application of genomics to the diseases plaguing the developing world may have huge medical and economic benefits for those countries and might even prevent armed conflict.

Authors:  Samuel Broder; Stephen L Hoffman; Peter J Hotez
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

Review 6.  Discovery of antivirals against smallpox.

Authors:  Stephen C Harrison; Bruce Alberts; Ellie Ehrenfeld; Lynn Enquist; Harvey Fineberg; Steven L McKnight; Bernard Moss; Michael O'Donnell; Hidde Ploegh; Sandra L Schmid; K Peter Walter; Julie Theriot
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Leishmaniasis.

Authors:  Philippe Desjeux
Journal:  Nat Rev Microbiol       Date:  2004-09       Impact factor: 60.633

8.  Security restrictions lead foreign students to snub US universities.

Authors:  Geoff Brumfiel
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

9.  Open-source biology.

Authors: 
Journal:  Nature       Date:  2004-09-30       Impact factor: 49.962

10.  A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis.

Authors:  C P Thakur; T P Kanyok; A K Pandey; G P Sinha; A E Zaniewski; H H Houlihan; P Olliaro
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.184
View more
  1 in total

1.  A course with a difference. Fighting infectious diseases with technology and knowledge-transfer.

Authors:  Arto Tapio Pulliainen; Jost Enninga; Elena Fernández-Arenas; Gareth Griffiths
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.